Emre Altınmakas

11PUBLICATIONS
112CO-AUTHORS
Medical infection agents (incl. prions)Tumour immunologyPredictive and prognostic markersRecommender systemsOpen access
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 20, 2025
The role of T1 hyperintensity in differentiating granulomatous prostatitis from prostate cancer: a retrospective analysis of 31 lesions.

Selahattin Durmaz, Mert Kılıç, Bilgen Coşkun

|Apr 08, 2025
The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and Application.

Anne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas

|Dec 03, 2024
The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application.

Anne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas

|Nov 24, 2023
MRI and PSMA PET/CT of Biochemical Recurrence of Prostate Cancer.

Muhammad O Awiwi, Migena Gjoni, Raghunandan Vikram

|Oct 05, 2023
The RSNA Cervical Spine Fracture CT Dataset.

Hui Ming Lin, Errol Colak, Tyler Richards

|Mar 25, 2022
Extramural venous invasion (EMVI) revisited: a detailed analysis of various characteristics of EMVI and their role as a predictive imaging biomarker in the neoadjuvant treatment response in rectal cancer.

Emre Altinmakas, Hakan Dogan, Orhun Cig Taskin

Pageof 2

Frequent Collaborators

5 joint publications

Hakan Dogan

4 joint publications

Felipe Kitamura

4 joint publications

Errol Colak

3 joint publications

Luciano M Prevedello